31 mRZO 1 APRILE A4 - Salute Regione Veneto

THORACIC
ONCOLOGY
PADOVA
Non-small cell lung cancer is one of the most
frequent and dismal solid tumors. In the latest
period it has become also one of the front
runners in translational research and in the
development of new therapeutic strategies.
The increasing knowledge of biological
heterogeneity of the disease and the new
complexity in treatment approach lead to
improved clinical outcome but also to the
necessity of continuous research advances’
update.
DAY 1 • FRIDAY 31st, MARCH 2017
NON-SMALL CELL LUNG CANCER:
FOCUS ON OLIGOMETASTATIC DISEASE
AND 2017 UPDATE
One essential point in providing optimal care to
lung cancer patients is the possibility to discuss
and share the diagnostic and therapeutic
program in a multidisciplinary team including
oncologists,
surgeons,
radiotherapists,
pulmonologist, pathologists, radiologists.
The aim of the conference is to provide update
on clinical cancer research in lung cancer and
discuss specific topic in a multidisciplinary
group, through lectures, clinical cases
discussion and opportunity to share opinions
10.40
12.50
Staging of oligometastatic lung Lunch
cancer
III SESSION
L. Evangelista
08.30
Integrated management of
Registration, introduction, authority
oligometastatic NSCLC
11.00
welcome
CHAIRMAN: P. Conte
Discussion
P. Conte, F. Rea
09.00
11.15
Break
∙ LECTURE ∙
Definition of oligometastatic
NSCLC in the context of innovative 11.30
∙ LECTURE ∙
treatments
Indications, role and timing of
P. Conte
surgical approach in
oligometastatic NSCLC
I SESSION
M. Alifano
Diagnosis and staging of
oligometastatic NSCLC
CHAIR PERSONS: S. Indraccolo,
II SESSION
M. Saetta
Locoregional Treatments of
oligometastatic NSCLC
10.00
The role of endoscopy in diagnosis
12.00
and management of
∙ ROUND TABLE ∙
oligometastatic desease
Locoregional approaches to
R. Trisolini
oligometastases
SHOOTER: L. Bonanno
10.20
EXPERT PANELIST: M. Iacobone,
Immunomarkers for better
characterization of oligometastatic F. Rea, U. Ricardi, P. Ruggieri,
R. Stramare
disease: role for diagnosis and
treatment
A.P. Dei Tos
14.00
Medical management of
oligoprogressive and/or slowly
progressive disease
G. Scagliotti
14.30
Multidisciplinary Tumor Board:
Clinical Cases
1st case report
PRESENTER: M. Schiavon
March 31 - April 01, 2017
PADOVA
and experiences between speakers and
attendees.
The TOP conference in 2017 will focus on the
management of oligometastatic Non-small cell
lung cancer (NSCLC).
The improvement of both surgical and non
surgical local treatments, the definition of
molecularly defined subgroups of NSCLC in
which we can plan long-term control of
metastatic disease and the new perspectives of
immunotherapy are elements that make the
15.30
Break
management
of
oligometastatic
and
oligoprogressing NSCLC one crucial point to
improve clinical outcome of NSCLC patients.
In this specific topic, sharing and discussing
multidisciplinary experience is essential and
may improve our clinical approach.
DAY 2 • SATURDAY 1st, APRIL 2017
16.00
Padova University Thoracic Cancer
Award
17.00
Adjourn, take home messages
P. Conte, F. Rea
18.00
Cocktail reception
09.00
∙ LECTURE ∙
Biological and therapeutic
implication of tumor heterogeneity
G. Pelosi
IV SESSION
Update on metastatic NSCLC
CHAIRMAN: P. Conte
09.30
Raising role of immunotherapy in
NSCLC
G. Scagliotti
Break
V SESSION
Update on locally advanced
disease
CHAIRMAN: F. Rea
11.30
Surgical approach
U. Pastorino
12.00
Radiotherapy
F. Alongi
12.30
Discussion
10.00
Panelist discussion
C. Aliberti, E. Bria, F. Calabrese,
L. Ceron, A. Cervino, G. Pasello
New option for oncogene addicted
NSCLCs: potential improvement in
first line setting
A. Ardizzoni
2nd case report
10.30
Panelist discussion
U. Fantoni, A. Favaretto,L.
Loreggian, G. Marulli, R.
Polverosi, A. Santo
11.00
PRESENTER: V. Polo
11.10
New option for oncogene addicted
NSCLCs: option for acquired
resistance
V. Gregorc
Discussion
12.40
Take home messages, conclusion
P. Conte, F. Rea
THORACIC
ONCOLOGY
PADOVA
NON-SMALL CELL LUNG CANCER:
FOCUS ON OLIGOMETASTATIC DISEASE
AND 2017 UPDATE
March 31 - April 01, 2017
PADOVA
SCIENTIFIC COMMITTEE
LOCATION
CME
Pier Franco Conte
Federico Rea
Aula Nievo, Palazzo del Bo,
University of Padova
Via 8 Febbraio, 2 - 35122 Padova
Certificate awarding 7,7 CME credits will be e-mailed within 90 days after the end of the congress. The
following medical sciences have been accredited for this Congress: Oncologists, surgeons,
pathologists, biologists, medical genetics, medical genetics lab.,radiation therapists, radiodiagnostic
therapists, neuro radiology, pharmacists, Occupational health, orthopedics, respiratory system
disease.
WITH THE PATRONAGE OF
THE PATRONAGE HAS BEEN REQUESTED TO
REGIONE DEL VENETO
COMUNE DI PADOVA
SUPPORTED BY AN INDEPENDENT EDUCATIONAL SPONSORSHIP FROM
DISCOG
ORGANIZING SECRETARIAT
via Pagliari, 4 - 26100 Cremona
tel 0372 23310 fax 0372 569605
[email protected] www.overgroup.eu